Julide Kurt Keles
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julide Kurt Keles has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Aziz Aksoy
Department of Bioengineering, Malatya Turgut Ozal University, 44210 Malatya, Türkiye
1 shared publication - Elif Emre
Firat Universitesi, Tip Fakultesi
1 shared publication - Eser Sert
Department of Computer Engineering, Malatya Turgut Ozal University, Malatya 44210, Türkiye
1 shared publication - Furkan Talo
Digital Transformation and Software Office, Rectorate, Firat University, Elazig 23119, Turkey
1 shared publication - Muhammed Yildirim
Department of Artificial Intelligence and Data Engineering, Firat University, Elazig 23119, Turkey
1 shared publication - Onur Çatak
Department of Ophtalmology, Faculty of Medicine, Firat University, 23119 Elazig, Turkey
1 shared publication
Latest Publications
- Open Access
Circulating Claudin-5 and Systemic Inflammatory Indices in Wet and Dry Age-Related Macular Degeneration
Background and Objectives: Age-related macular degeneration (AMD) is a multifactorial retinal disease in which inflammation and blood-retinal barrier dysfunction may contribute to disease pathogenesis. Claudin-5 is a key tight-junction protein involved in endothelial barrier integrity. Hemogram-derived indices such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and pan-immune-inflammation value (PIV) reflect systemic inflammatory status. This study aimed to evaluate circulating claudin-5 levels and systemic inflammatory indices in patients with wet and dry AMD and to investigate their associations with visual function. Materials and Methods: This prospective case–control study included 90 participants: 30 patients with wet AMD, 30 patients with dry AMD, and 30 healthy controls. All participants underwent detailed ophthalmologic examination, including best-corrected visual acuity (BCVA) assessment and optical coherence tomography. Serum claudin-5 levels were analyzed by enzyme-linked immunosorbent assay, and NLR, PLR, MLR, and PIV were calculated from complete blood count parameters. Group comparisons, correlation analyses, and age-adjusted analyses were performed using appropriate statistical methods. Results: Age differed significantly among the groups (p = 0.032), with the highest median age in the dry AMD group. BCVA (logMAR) also differed significantly (p < 0.001), and both AMD groups had worse visual acuity than controls. Median serum claudin-5 levels were 2.42 in controls, 3.28 in the wet AMD group, and 3.10 in the dry AMD group, with no significant between-group difference (p = 0.280). NLR, MLR, and PIV were also comparable among the groups (p = 0.310, p = 0.410, and p = 0.752, respectively). PLR differed among the groups (p = 0.019), and post hoc analysis showed higher PLR values in the dry AMD group than in the wet AMD group (p = 0.013). However, this difference was no longer statistically significant after adjustment for age (adjusted p = 0.098). Serum claudin-5 was not significantly correlated with age, BCVA, NLR, PLR, MLR, or PIV. Conclusions: Circulating claudin-5 did not differ significantly across AMD phenotypes and was not associated with age, visual function, or systemic inflammatory indices. Although PLR differed between wet and dry AMD before adjustment for age, the overall findings suggest that single-point peripheral serum measurements of claudin-5 may have limited utility in reflecting local retinal barrier-related changes in AMD. Larger longitudinal studies are needed to clarify its potential biomarker role.
Open AccessCirculating Claudin-5 and Systemic Inflammatory Indices in Wet and Dry Age-Related Macular Degeneration
Background and Objectives: Age-related macular degeneration (AMD) is a multifactorial retinal disease in which inflammation and blood-retinal barrier dysfunction may contribute to disease pathogenesis. Claudin-5 is a key tight-junction protein involved in endothelial barrier integrity. Hemogram-derived indices such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), and pan-immune-inflammation value (PIV) reflect systemic inflammatory status. This study aimed to evaluate circulating claudin-5 levels and systemic inflammatory indices in patients with wet and dry AMD and to investigate their associations with visual function. Materials and Methods: This prospective case–control study included 90 participants: 30 patients with wet AMD, 30 patients with dry AMD, and 30 healthy controls. All participants underwent detailed ophthalmologic examination, including best-corrected visual acuity (BCVA) assessment and optical coherence tomography. Serum claudin-5 levels were analyzed by enzyme-linked immunosorbent assay, and NLR, PLR, MLR, and PIV were calculated from complete blood count parameters. Group comparisons, correlation analyses, and age-adjusted analyses were performed using appropriate statistical methods. Results: Age differed significantly among the groups (p = 0.032), with the highest median age in the dry AMD group. BCVA (logMAR) also differed significantly (p < 0.001), and both AMD groups had worse visual acuity than controls. Median serum claudin-5 levels were 2.42 in controls, 3.28 in the wet AMD group, and 3.10 in the dry AMD group, with no significant between-group difference (p = 0.280). NLR, MLR, and PIV were also comparable among the groups (p = 0.310, p = 0.410, and p = 0.752, respectively). PLR differed among the groups (p = 0.019), and post hoc analysis showed higher PLR values in the dry AMD group than in the wet AMD group (p = 0.013). However, this difference was no longer statistically significant after adjustment for age (adjusted p = 0.098). Serum claudin-5 was not significantly correlated with age, BCVA, NLR, PLR, MLR, or PIV. Conclusions: Circulating claudin-5 did not differ significantly across AMD phenotypes and was not associated with age, visual function, or systemic inflammatory indices. Although PLR differed between wet and dry AMD before adjustment for age, the overall findings suggest that single-point peripheral serum measurements of claudin-5 may have limited utility in reflecting local retinal barrier-related changes in AMD. Larger longitudinal studies are needed to clarify its potential biomarker role.
- Open Access
- 19 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2352
MidFusionEfficientV2: Improving Ophthalmic Diagnosis with Mid-Level RGB–LBP Fusion and SE Attention
Background/Objectives: Early diagnosis of eye diseases is critically important for enhancing individuals’ quality of life and reducing the risk of vision loss. In this study, a deep learning-based hybrid model called MidFusionEfficientV2 has been proposed to classify eye diseases, including uveitis, conjunctivitis, cataract, eyelid drooping, and normal conditions. Methods: The model presents a dual-branch architecture that combines an RGB image branch with an EfficientNetV2-S architecture and a specialized texture branch based on Local Binary Pattern (LBP) transformation at an intermediate level. Thanks to the Squeeze-and-Excitation (SE) blocks integrated into the LBP branch, channel-based attention mechanisms have been activated, enhancing the prominence of textural features. The features obtained from the RGB and LBP branches were combined at an intermediate level and transferred to the classification stage. Results: Experimental studies on the five-class eye disease dataset from the Mendeley Data platform have shown that the proposed model outperformed six strong models (ResNetV2, ConvNeXt, DenseNet-121, EfficientNet-B1, MobileNetV3 Large, and EfficientNetV2-S) with an accuracy of 98%. Especially in the difficult-to-diagnose uveitis class, recall and F1 scores of 97% and 94%, respectively, were achieved. Conclusions: The results show that a moderate combination of color and texture features significantly improves classification performance, and that MidFusionEfficientV2 offers a reliable and effective solution for the automatic diagnosis of eye diseases.
- 19 March 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (6) , 2352
Open AccessMidFusionEfficientV2: Improving Ophthalmic Diagnosis with Mid-Level RGB–LBP Fusion and SE Attention
Background/Objectives: Early diagnosis of eye diseases is critically important for enhancing individuals’ quality of life and reducing the risk of vision loss. In this study, a deep learning-based hybrid model called MidFusionEfficientV2 has been proposed to classify eye diseases, including uveitis, conjunctivitis, cataract, eyelid drooping, and normal conditions. Methods: The model presents a dual-branch architecture that combines an RGB image branch with an EfficientNetV2-S architecture and a specialized texture branch based on Local Binary Pattern (LBP) transformation at an intermediate level. Thanks to the Squeeze-and-Excitation (SE) blocks integrated into the LBP branch, channel-based attention mechanisms have been activated, enhancing the prominence of textural features. The features obtained from the RGB and LBP branches were combined at an intermediate level and transferred to the classification stage. Results: Experimental studies on the five-class eye disease dataset from the Mendeley Data platform have shown that the proposed model outperformed six strong models (ResNetV2, ConvNeXt, DenseNet-121, EfficientNet-B1, MobileNetV3 Large, and EfficientNetV2-S) with an accuracy of 98%. Especially in the difficult-to-diagnose uveitis class, recall and F1 scores of 97% and 94%, respectively, were achieved. Conclusions: The results show that a moderate combination of color and texture features significantly improves classification performance, and that MidFusionEfficientV2 offers a reliable and effective solution for the automatic diagnosis of eye diseases.
- Open Access
Can the Posterior Segment Findings of the Eye and Serum Microbiota Metabolites Be a Biomarker in Schizophrenia?
Background and Objectives: In many neurodegenerative diseases, the pathological changes occurring in the central nervous system may be reflected in the periphery. The aim of this study was to examine the possible relationship between the retina, choroid, and nerve fibre layer thicknesses measured on optic coherence tomography (OCT) and the serum microbiota metabolite levels of trimethyl amine-N-oxide (TMAO), S-equol, Indoxyl sulphate (IS), and Maresin 1 (MaR1). Materials and Methods: This study included a total of 60 subjects, comprising 30 patients diagnosed with schizophrenia and a control group of 30 healthy individuals. A sociodemographic form was given to all the subjects and the Positive and Negative Syndrome Scale (PANSS) to the schizophrenia patients. The eye fundus was evaluated with OCT. A 5 mL blood sample was taken from the arm of each subject, and the microbiota metabolite levels of TMAO, S-equol, IS, and MaR1 were examined. Results: The retina nerve fibre layer (RNFL) analysis results showed that the RNFL superior (p = 0.016), inferior (p = 0.002), central choroid (p = 0.033), nasal choroid (p = 0.004), temporal choroid (p = 0.038), and TMAO (p = 0.001) values were significantly lower in the schizophrenia patients than in the control group. In the patient group, a significant negative correlation was determined between the RNFL temporal measurements and IS, as well as a significant positive correlation between the central choroid measurement and the nasal choroid and temporal choroid measurements and between the nasal choroid and temporal choroid measurements. A statistically significant positive correlation was seen between S-equol and TMAO. A significant negative correlation was seen between the MaR1 level and age and disease duration. Conclusions: The study results showed that fundus changes are associated with serum microbiota metabolite levels in schizophrenia patients. Therefore, these parameters may be considered potential exploratory biomarkers; however, their clinical applicability requires validation in larger longitudinal studies.
Open AccessCan the Posterior Segment Findings of the Eye and Serum Microbiota Metabolites Be a Biomarker in Schizophrenia?
Background and Objectives: In many neurodegenerative diseases, the pathological changes occurring in the central nervous system may be reflected in the periphery. The aim of this study was to examine the possible relationship between the retina, choroid, and nerve fibre layer thicknesses measured on optic coherence tomography (OCT) and the serum microbiota metabolite levels of trimethyl amine-N-oxide (TMAO), S-equol, Indoxyl sulphate (IS), and Maresin 1 (MaR1). Materials and Methods: This study included a total of 60 subjects, comprising 30 patients diagnosed with schizophrenia and a control group of 30 healthy individuals. A sociodemographic form was given to all the subjects and the Positive and Negative Syndrome Scale (PANSS) to the schizophrenia patients. The eye fundus was evaluated with OCT. A 5 mL blood sample was taken from the arm of each subject, and the microbiota metabolite levels of TMAO, S-equol, IS, and MaR1 were examined. Results: The retina nerve fibre layer (RNFL) analysis results showed that the RNFL superior (p = 0.016), inferior (p = 0.002), central choroid (p = 0.033), nasal choroid (p = 0.004), temporal choroid (p = 0.038), and TMAO (p = 0.001) values were significantly lower in the schizophrenia patients than in the control group. In the patient group, a significant negative correlation was determined between the RNFL temporal measurements and IS, as well as a significant positive correlation between the central choroid measurement and the nasal choroid and temporal choroid measurements and between the nasal choroid and temporal choroid measurements. A statistically significant positive correlation was seen between S-equol and TMAO. A significant negative correlation was seen between the MaR1 level and age and disease duration. Conclusions: The study results showed that fundus changes are associated with serum microbiota metabolite levels in schizophrenia patients. Therefore, these parameters may be considered potential exploratory biomarkers; however, their clinical applicability requires validation in larger longitudinal studies.